apolipoprotein C3
| GO Term | Evidence Code | PMID |
|---|---|---|
| triglyceride metabolic process | ||
| G protein-coupled receptor signaling pathway | ||
| negative regulation of triglyceride catabolic process | ||
| negative regulation of triglyceride catabolic process | ||
| negative regulation of very-low-density lipoprotein particle remodeling |
| GO Term | Evidence Code | PMID |
|---|---|---|
| intermediate-density lipoprotein particle | ||
| intermediate-density lipoprotein particle | ||
| spherical high-density lipoprotein particle | ||
| spherical high-density lipoprotein particle | ||
| chylomicron |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein binding | ||
| phospholipid binding | ||
| phospholipid binding | ||
| cholesterol binding | ||
| enzyme regulator activity |
| InterPro |
|---|
| Apolipoprotein CIII superfamily |
| Apolipoprotein CIII |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111370 | apolipoprotein C-III deficiency | |
| DOID:10603 | glucose intolerance | |
| DOID:13809 | familial combined hyperlipidemia | |
| DOID:1561 | cognitive disorder | |
| DOID:3145 | hyperlipoproteinemia type III | |
| DOID:3393 | coronary artery disease | |
| DOID:684 | hepatocellular carcinoma | |
| DOID:784 | chronic kidney disease | |
| DOID:9744 | type 1 diabetes mellitus |
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 345 | RGD:2136 | ||
| 11814 | RGD:2136 | MOUSE63358 | |
| 406187 | PIGXX35461 | ||
| 408009 | BOVIN06508 | ||
| 442970 | CANLF15257 | ||
| 100135481 | CAVPO10135 | ||
| 100413593 | CALJA02903 | ||
| 100477899 | AILME12515 | ||
| 100599045 | NOMLE10282 | ||
| 100774705 | CRIGR21439 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025